Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
US6337321B1 · kind B1 · utility
9Cited by
0References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 8, 1998 |
| Grant date | Jan 8, 2002 |
| Priority date | — |
| Expiry date | May 8, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2800/107
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Vascular function and structure is maintained or improved by long term administration of physiologically acceptable compounds which enhance the level of endogenous nitric oxide or other intermediates in the NO induced relaxation pathway in the host. Alternatively, or in combination, other compounds may be administered which provide for short term enhancement of nitric oxide, either directly or by physiological processes
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.